• No results found

v Impoverishing Health Expenditure

In document 1Household Spending and Impoverishment (Page 166-172)

Health Financing and Household Health Expenditure in Chile

III. v Impoverishing Health Expenditure

Impoverishing Health Expenditures (IHE) are those which push a household below the poverty line. Data from the ENSGS survey indicate an incidence of poverty in Chile of 5.4% (based on the national indigence line). If health spend- ing is subtracted from total household consumption, the incidence increases to 6.6%, indicating that the incidence of IHE is 1.2%. As shown in Table 7, impoverishing health expenditures are concentrated in the poorest quintile, where the poverty line is situated. In this quintile there are no statistically signifi- cant differences between insured and uninsured groups, i.e., there is no evidence that insurance reduced the likelihood of becoming impoverished because of high health spending.

Table 7

Impoverishing Health Expenditure Incidence, by Per Capita Expenditure Quintile and Insurance Type, 2005 Per Capita

Expenditure Quintile

Insurance Type (%) No

Insurance FONASA A FONASA B/C/D ISAPRE InsuranceOther Total

1 4.9 3.2 8.4 0.0* 0.0* 5.3 2 0.0 0.7 0.0 0.0* 0.0* 0.2 3 0.0 0.0 0.2 0.0 0.0* 0.1 4 0.0 0.0 0.2 0.0 0.0 0.1 5 0.0 0.0* 0.3 0.0 0.0 0.1 Total 1.3 1.7 1.3 0.0 0.0 1.2

Note: * Statistics calculated based on less than 30 observations. Source: Authors’ calculations based on ENSGS, 2005.

IV. Conclusions

This study confirms the hypothesis of a number of experts who consider that government sources underestimate household OOP expenditure on health, particularly with respect to expenditures on drugs. The official numbers indi- cate that total health expenditure represents 5.4% of GDP, almost one third of which is financed out-of-pocket. However, data from the ENSGS survey show that out-of-pocket spending is almost twice as high as believed, and that total health expenditure thus amounts to 6.9% of GDP. In terms of equity and finan- cial risk protection for households, this finding denotes a worse situation than what was initially believed – almost half of health expenditure in Chile is appar- ently financed directly by household OOP spending. It is not surprising that the main source of OOP spending is for supplies and medications, since these items are not adequately covered by FONASA or ISAPREs.

The results show that OOP expenditures increase with income: the weal- thiest households have higher levels of utilization and consume more expensive types of care, which are presumably of higher quality and more resource-inten- sive. This indicates that Chilean households consider healthcare a superior good; accordingly, one can expect health spending as a percentage of GDP to continue to increase in the future, as the Chilean GDP increases. Increases in health spending as income rises also reflect the presence of financial barriers to access for the poorest, including low-income households with insurance. However, there is evidence that insured households have considerably higher levels of utilization of medical consultations than uninsured households regardless of whether the latter are poor or not.

With the exception of FONASA Group A, insurance schemes do not appear to decrease OOP expenses per consultation. However, because of the relatively high reimbursements provided by insurance schemes, one may con- clude that they provide access to more expensive types of care, which are presum- ably of higher quality and more resource-intensive, although provided at the same cost as for uninsured people.

In particular, CHE should be a topic of concern because Chile has one of the highest incidences in the world: each month, 6.4% of all households spend on health more than 40% of their capacity-to-pay. Catastrophic expen- ditures occur mainly to pay for supplies and drugs, but medical treatments and hospitalization are also important components. In contrast to earlier results based on the CASEN survey, which showed that the incidence of CHE in Chile was concentrated in the poorest sectors of the population, this study shows that the

incidence of catastrophic expenditure does not depend on income. The inci- dence also does not depend on the type of insurance, a finding that indicates that FONASA and ISAPREs do not adequately address the problem of providing households with financial protection against CHE.

The amount of money required annually to finance excess costs in these households is $ 466 million USD PPP, or 3% of all health expenditure. To cover this gap, the average health insurance premium would need to increase by 11%, or alternatively, government financing would need to increase by 16%.

Unlike catastrophic expenditure, the incidence of impoverishing expen- diture is on average very low in Chile, especially in high - or moderate-income households. Although IHE affects a small proportion of the population overall, it is heavily concentrated in the poorest quintile which has an incidence of 5.3%. A future challenge will be to examine health needs that remain unmet because of barriers to access. This information will disclose the reasons why some households underuse healthcare, such as low levels of need or access. Another desirable goal is to measure the monetary value of insurance reim- bursements, given the differences between plans offered by FONASA and ISAPREs. The level of reimbursement is certain to influence both usage levels and the likelihood of catastrophic expenditures. Moreover, future surveys should be designed to control appropriately for health status and for the endogeneity of health status regarding health service needs. This, in turn, would lead to better estimates of the effect of insurance on usage and health expenditures. Finally, it is necessary to evaluate whether insurance is associated with moral risk issues in supply or demand that might push utilization and prices above optimum levels.

References

Bitrán R, Giedion U, Muñoz R. (2004). Fondos de Riesgo, Ahorro y Prevención: Estudio Regional de Políticas para la protección de los más pobres de los efectos de los choques de salud – Estudio de caso de Chile. Washington, DC: World Bank.

Cavagnero E, Carrin G, Xu K, Aguilar-Rivera AM. (2006). Health Financing in Argentina: an Empirical Study of Health Care Expenditure and Utilization. Innovations in Health Financing Working Paper No.8. Mexico, DF: Fundación Mexicana para la Salud, and Instituto Nacional de Salud Pública. Chile Ministry of Health, World Health Organization. (2005). Estudio Nacional Sobre Satisfacción y

Gasto en Salud (ENSGS). Informe de Resultados: Módulos “F” y “G”, Gasto de Bolsillo en Salud. Santiago: Chile Ministry of Health, World Health Organization.

Chile Ministry of Health, World Health Organization. (2005). Estudio Nacional Sobre Satisfacción y Gasto En Salud - Informe de Resultados: Satisfacción con el Sistema de Salud. Santiago: Chile Ministry of Health, World Health Organization.

Chile Ministry of Health, World Health Organization. (2006). Estudio Nacional Sobre Satisfacción y Gasto En Salud 2005, Base de Datos en formato SPSS, Versión 280606, División de Planificación Sanitaria, Subsecretaría de Salud Pública.

Chile Ministry of Planning and Cooperation (MIDEPLAN). (2006). Casen 2006, Encuesta de Caracter- ización Socioeconómica Nacional, Documento Metodológico. Santiago: Chile Ministry of Planning and Cooperation (MIDEPLAN).

Gakidou E, Murray C, Frenk J. (2000). A Framework for Measuring Health Inequality. Geneva: World Health Organization.

Gertler P, Gruber J. (2002). Insuring Consumption Against Illness. American Economic Review, 92(1):51-70. Jacobson B. Monitoring Health Inequalities Powerpoint Presentation, London Health Observatory,

2003. Available at: http://healthinequalities.thehealthwell.info/node/27577 (accessed: Jan 20, 2012). Knaul F, Arreola-Ornelas H, Méndez O. (2005). Protección Financiera en Salud: México, 1992 a 2004.

Cuernavaca: Instituto Nacional de Salud Pública, México.

Levy H, Meltzer D. (2001). What Do We Really Know About Whether Health Insurance Affects Health? Economic Research Initiative on the Uninsured, University of Michigan.

Murray C, Knaul F, Musgrove P, Xu K, Kawabata K. (2001). Defining and Measuring Fairness in Financial Contribution to the Health System. Geneva: World Health Organization.

Pastor PN, Makuc DM, Reuben C, Xia H. (2002). Chartbook on Trends in the Health of Americans. Health, United States 2002. Hyattsville, MD: National Center for Health Statistics.

O’Donnell O, van Doorslaer E, Rannan-Eliya R, et al. (2005). Explaining the Incidence of Catastrophic Expenditures on Health Care: Comparative Evidence from Asia. EQUITAP (5).

O’Donnell O, van Doorslaer E, Wagstaff A, Lindelow M. (2008). Analyzing Health Equity Using Household Survey Data – A Guide to Techniques and their Implementation. Washington, DC: World Bank. World Bank. (2003). Quantitative Techniques for Health Equity Analysis –Technical Note No. 7– The

Concentration Index. Washington, DC: World Bank.

World Bank. (2003). Quantitative Techniques for Health Equity Analysis –Technical Note No. 11– Multi- variate Analysis of Health Data: Non-Linear Estimators. Washington, DC: World Bank.

World Bank. (2003). Quantitative Techniques for Health Equity Analysis –Technical Note No.15– Unraveling Causes: the Oaxaca Approach. Washington, DC: World Bank.

World Bank. (2003). Quantitative Techniques for Health Equity Analysis –Technical Note No. 17– Decom- posing the Redistributive Effect of Health Care Payments. Washington, DC: World Bank.

World Bank. (2003). Quantitative Techniques for Health Equity Analysis –Technical Note No. 20– Data for Health Equity Analysis Requirements, Sources, and Issues in Analysis. Washington, DC: World Bank. Tokman M. (2000). Age Segmentation in the Chilean Health System. Estudios de Economía, 27(1). Valdivia M, Diaz JJ. (2007). Financial Protection Against Health Catastrophes in Latin America: Some

Conceptual and Methodological Issues. iHEA 2007 6th World Congress: Explorations in Health

Economics Paper.

Wagstaff A. (2001). Measuring Equity in Health. The World Health Organization’s latest World Care Financing – Reflections on (and Alternatives to) the World Health Organization’s Fairness of Financing Index. Washington, DC: World Bank.

Wagstaff A. (2008). Measuring Financial Protection in Health. World Bank Policy Research Working Paper No. 4554. Washington, DC: World Bank.

Wagstaff A, van Doorslaer E. (2003). Catastrophe and Impoverishment in Paying for Health Care: With Applications to Vietnam 1993-98. Health Economics, 12: 921-34.

World Health Organization. (2001). Proposed Strategies for Health Systems Performance Assessment – Summary Document, World Health Organization.

World Health Organization. (2001). Report of the Scientific Peer Review Group on Health Systems Performance Assessment – Chapter X Fairness in Financial Contribution. Geneva: World Health Organization.

Xu K. (2005). Distribution of Health Payments and Catastrophic Expenditures – Methodology, WHO Health Financing Policy Discussion Paper. Geneva: World Health Organization.

Xu K, Evans D, Kawabata K, Zeramdini R, Klavus J, Murray C. (2003). Household Catastrophic Health Expenditure: a Multicountry Analysis. Geneva: World Health Organization.

Chapter 7

Risk Factors

In document 1Household Spending and Impoverishment (Page 166-172)